# Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy

Study · id `cardio:ct-nct01912677` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01912677](<https://clinicaltrials.gov/study/NCT01912677>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01912677

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 894 participants.

## Technical summary

Registry record NCT01912677. Randomized; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2017-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 894 participants (enrolled count; ClinicalTrials.gov record NCT01912677, source copy `cardio:ctgov-nct01912677-2018-11-08`, retrieved 2026-10-26)
- Started: 2015-04 (actual) (ClinicalTrials.gov record NCT01912677, source copy `cardio:ctgov-nct01912677-2018-11-08`, retrieved 2026-10-26)
- Primary completion: 2017-09 (actual) (ClinicalTrials.gov record NCT01912677, source copy `cardio:ctgov-nct01912677-2018-11-08`, retrieved 2026-10-26)
- Completion: 2017-12 (actual) (ClinicalTrials.gov record NCT01912677, source copy `cardio:ctgov-nct01912677-2018-11-08`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT01912677, source copy `cardio:ctgov-nct01912677-2018-11-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01912677-2018-11-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy
- Condition: Hypertension in Pregnancy
- Condition: Preeclampsia
- Intervention (Drug): Nifedipine
- Intervention (Drug): Labetalol
- Intervention (Drug): Methyldopa
- Lead sponsor: Gynuity Health Projects
- Lead sponsor class: OTHER
- Collaborator: Government Medical College, Nagpur
- Collaborator class: INDUSTRY
- Collaborator: Daga Memorial Women's Hospital, Nagpur, India
- Collaborator class: OTHER
- Collaborator: University of British Columbia
- Collaborator class: OTHER
- Collaborator: Bill and Melinda Gates Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Nifedipine (`cardio:nifedipine`)
- Registry lists this organization as a collaborator: University of British Columbia (`cardio:org-university-of-british-columbia`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial (`cardio:pubmed-31378394`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0c9015819fd5105ca9db40911b10e3e739c9d85fee716c707d7a0d2835b79ede
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
